Approval of COVID-19 test in the UK under CTDA legislation

Paris, France and Camberley, UK – 26 November 2021 – Novacyt (EURONEXT
GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics,
announces that, further to the announcement on 2 November 2021, the Company’s
genesig® COVID-19 Real-Time PCR test has been approved in the UK under the UK Health
Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment)
Regulations 2021 (“CTDA”). The genesig® COVID-19 test is Novacyt’s first test to be added
to the CTDA register and the Company will now work to resume the sale of the product in
the UK.